Regencell Cash from 2010 to 2025

RGC Stock  USD 3.75  0.17  4.75%   
Regencell Bioscience's Cash is decreasing over the years with slightly volatile fluctuation. Cash is expected to dwindle to about 2.5 M. Cash is the total amount of money in the form of currency that Regencell Bioscience Holdings has in its possession. This includes all bills, coins, and funds in bank accounts. View All Fundamentals
 
Cash  
First Reported
2002-03-31
Previous Quarter
M
Current Value
M
Quarterly Volatility
166.9 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Regencell Bioscience financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Regencell Bioscience's main balance sheet or income statement drivers, such as Depreciation And Amortization of 637.5 K, Interest Expense of 19.8 K or Selling General Administrative of 3.1 M, as well as many indicators such as Price To Sales Ratio of 0.36, Dividend Yield of 0.0 or Days Sales Outstanding of 12.61. Regencell financial statements analysis is a perfect complement when working with Regencell Bioscience Valuation or Volatility modules.
  
Check out the analysis of Regencell Bioscience Correlation against competitors.

Latest Regencell Bioscience's Cash Growth Pattern

Below is the plot of the Cash of Regencell Bioscience Holdings over the last few years. Cash refers to the most liquid asset of Regencell Bioscience, which is listed under current asset account on Regencell Bioscience Holdings balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Regencell Bioscience customers. The amounts must be unrestricted with restricted cash listed in a different Regencell Bioscience account. It is the total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts. Regencell Bioscience's Cash historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Regencell Bioscience's overall financial position and show how it may be relating to other accounts over time.
Cash10 Years Trend
Slightly volatile
   Cash   
       Timeline  

Regencell Cash Regression Statistics

Arithmetic Mean111,139,356
Geometric Mean14,627,357
Coefficient Of Variation108.09
Mean Deviation109,240,564
Median109,500,000
Standard Deviation120,135,795
Sample Variance14432.6T
Range280.8M
R-Value(0.82)
Mean Square Error5034.1T
R-Squared0.67
Significance0.000096
Slope(20,723,086)
Total Sum of Squares216489.1T

Regencell Cash History

20252.5 M
20242.7 M
2023M
20221.6 M
20216.4 M
202059.4 K
2019387 K

Other Fundumenentals of Regencell Bioscience

Regencell Bioscience Cash component correlations

About Regencell Bioscience Financial Statements

Regencell Bioscience stakeholders use historical fundamental indicators, such as Regencell Bioscience's Cash, to determine how well the company is positioned to perform in the future. Although Regencell Bioscience investors may analyze each financial statement separately, they are all interrelated. For example, changes in Regencell Bioscience's assets and liabilities are reflected in the revenues and expenses on Regencell Bioscience's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Regencell Bioscience Holdings. Please read more on our technical analysis and fundamental analysis pages.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Regencell Bioscience offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Regencell Bioscience's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Regencell Bioscience Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Regencell Bioscience Holdings Stock:
Check out the analysis of Regencell Bioscience Correlation against competitors.
You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Regencell Bioscience. If investors know Regencell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Regencell Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.33)
Return On Assets
(0.28)
Return On Equity
(0.43)
The market value of Regencell Bioscience is measured differently than its book value, which is the value of Regencell that is recorded on the company's balance sheet. Investors also form their own opinion of Regencell Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Regencell Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Regencell Bioscience's market value can be influenced by many factors that don't directly affect Regencell Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Regencell Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Regencell Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Regencell Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.